AB
About
ASCIL Biopharm is a drug-delivery company developing proprietary miniaturized injectable and locally acting therapeutics to enhance the safety, effectiveness, and convenience of administration of drugs for chronic high burden diseases. The company's mission is to create pharmaceutical products and therapeutic treatments of improved efficacy, comfort, and compliance through its new patented DDS technology platforms.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 820 investors are based in Barcelona, Catalonia, Spain.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Barcelona, Spain
Contact Information
linkedin.com/in/••••••••
Find more investors like ASCIL
Search Investors